Rentokil Initial Forecast, price target & analysts
Rentokil Initial Target price 2025 - Analyst rating & recommendation
Rentokil Initial Classifications & Recommendation:
Rentokil Initial Price Target
| Target Price | £4.59 |
| Price | £4.42 |
| Potential |
3.80%
register free of charge
|
| Number of Estimates | 20 |
|
20 Analysts have issued a price target Rentokil Initial 2026 .
The average Rentokil Initial target price is £4.59.
This is
3.80%
register free of charge
£5.99
35.35%
register free of charge
£3.03
31.48%
register free of charge
|
|
| A rating was issued by 26 analysts: 16 Analysts recommend Rentokil Initial to buy, 9 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Rentokil Initial stock has an average upside potential 2026 of
3.80%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion £ | 7.18 | 8.02 |
| 1.13% | 11.65% | |
| EBITDA Margin | 19.78% | 20.63% |
| 4.84% | 4.32% | |
| Net Margin | 5.65% | 9.50% |
| 20.33% | 68.21% |
22 Analysts have issued a sales forecast Rentokil Initial 2025 . The average Rentokil Initial sales estimate is
This results in the following potential growth metrics:
20 Analysts have issued an Rentokil Initial EBITDA forecast 2025. The average Rentokil Initial EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
22 Rentokil Initial Analysts have issued a net profit forecast 2025. The average Rentokil Initial net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share £ | 0.16 | 0.30 |
| 20.00% | 87.50% | |
| P/E | 14.66 | |
| EV/Sales | 1.93 |
22 Analysts have issued a Rentokil Initial forecast for earnings per share. The average Rentokil Initial EPS is
This results in the following potential growth metrics and future valuations:
Rentokil Initial...
Current Rentokil Initial Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Berenberg Bank |
Locked
➜
Locked
|
Locked | Nov 03 2025 |
| Citigroup |
Locked
➜
Locked
|
Locked | Oct 24 2025 |
| UBS |
Locked
➜
Locked
|
Locked | Oct 17 2025 |
| Bernstein |
Locked
➜
Locked
|
Locked | Oct 07 2025 |
| Berenberg Bank |
Locked
➜
Locked
|
Locked | Sep 29 2025 |
| JP Morgan Cazenove |
Locked
➜
Locked
|
Locked | Aug 11 2025 |
| RBC Capital Markets |
Locked
➜
Locked
|
Locked | Aug 01 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Berenberg Bank:
Locked
➜
Locked
|
Nov 03 2025 |
|
Locked
Citigroup:
Locked
➜
Locked
|
Oct 24 2025 |
|
Locked
UBS:
Locked
➜
Locked
|
Oct 17 2025 |
|
Locked
Bernstein:
Locked
➜
Locked
|
Oct 07 2025 |
|
Locked
Berenberg Bank:
Locked
➜
Locked
|
Sep 29 2025 |
|
Locked
JP Morgan Cazenove:
Locked
➜
Locked
|
Aug 11 2025 |
|
Locked
RBC Capital Markets:
Locked
➜
Locked
|
Aug 01 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
